Chifotides Helen T, Catalan Kemal V, Dunbar Kim R
Department of Chemistry, Texas A&M University, College Station, Texas 77843, USA.
Inorg Chem. 2003 Dec 29;42(26):8739-47. doi: 10.1021/ic034737b.
The reactions of [Rh(2)(DTolF)(2)(CH(3)CN)(6)]BF(4) (1) (DTolF = N,N'-di-p-tolylformamidinate) with 2,2'-bipyridine (bpy) and 1,10-phenanthroline (phen) proceed with substitution of CH(3)CN molecules to give products with the N-N ligands chelating in an equatorial-equatorial (eq-eq) fashion. Compound 1 reacts with 1 equiv of bpy to yield a mixture of [Rh(2)(DTolF)(2)(bpy)(CH(3)CN)(3)]BF(4).(CH(3))(2)CO (2a) and [Rh(2)(DTolF)(2)(bpy)(CH(3)CN)(4)]BF(4) (2b). Compound 2a crystallizes in the monoclinic space group P2(1)/n with a = 13.5856(2) A, b = 18.0402(2) A, c = 21.4791(3) A; alpha = 90 degrees, beta = 101.044(1) degrees, gamma = 90 degrees; V = 5167.27(12) A(3), Z = 4, R = 0.0531, and R(w) = 0.0948. Compound 2b crystallizes in the monoclinic space group P2(1)/n with a = 10.9339(2) A, b = 24.4858(1) A, c = 19.4874(3) A; alpha = 90 degrees, beta = 94.329(1) degrees, gamma = 90 degrees; V = 5202.38(13) A(3), Z = 4, R = 0.0459, and R(w) = 0.1140. The reaction of compound 1 with 2 equiv of bpy affords [Rh(2)(DTolF)(2)(bpy)(2)(CH(3)CN)]BF(4) (3) which crystallizes in the monoclinic space group P2(1)/a with a = 19.4534(4) A, b = 13.8298(3) A, c = 19.8218(5) A; alpha = 90 degrees, beta = 109.189(1) degrees, gamma = 90 degrees; V = 5036.5(2) A(3), Z = 4, R = 0.0589, and R(w) = 0.0860. Compound 1 reacts with 1 equiv of phen to form [Rh(2)(DTolF)(2)(phen)(CH(3)CN)(3)]BF(4).2C(2)H(5)OC(2)H(5) (4) which crystallizes in the triclinic space group P1macro with a = 12.6346(2) A, b = 13.5872(2) A, c = 19.0597(3) A; alpha = 71.948(1) degrees, beta = 73.631(1) degrees, gamma = 71.380(1) degrees; V = 2886.70(8) A(3), Z = 2, R = 0.0445, and R(w) = 0.1207. A notable feature of the cations in 2a, 3, and 4 is the presence of only one axial (ax) CH(3)CN ligand, a fact that can be attributed to the steric effect of the formamidinate bridging ligands. Compounds 2a, 2b, 3, and 4 were fully characterized by X-ray crystallography and (1)H NMR spectroscopy, whereas [Rh(2)(DTolF)(2)(phen)(2)(CH(3)CN)(2)]BF(4) (5) was characterized by (1)H NMR spectroscopy.
[Rh₂(DTolF)₂(CH₃CN)₆][BF₄]₂ (1)(DTolF = N,N'-二对甲苯基甲脒)与2,2'-联吡啶(bpy)和1,10-菲咯啉(phen)反应,通过CH₃CN分子的取代反应,生成N-N配体以赤道-赤道(eq-eq)方式螯合的产物。化合物1与1当量的bpy反应,生成[Rh₂(DTolF)₂(bpy)(CH₃CN)₃][BF₄]₂·(CH₃)₂CO (2a)和[Rh₂(DTolF)₂(bpy)(CH₃CN)₄][BF₄]₂ (2b)的混合物。化合物2a在单斜空间群P2₁/n中结晶,a = 13.5856(2) Å,b = 18.0402(2) Å,c = 21.4791(3) Å;α = 90°,β = 101.044(1)°,γ = 90°;V = 5167.27(12) ų,Z = 4,R = 0.0531,R(w) = 0.0948。化合物2b在单斜空间群P2₁/n中结晶,a = 10.9339(2) Å,b =